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Cryo-EM structure of the volume-regulated anion
channel LRRC8D isoform identifies features
important for substrate permeation
Ryoki Nakamura1,11, Tomohiro Numata 2,11, Go Kasuya 3,11✉, Takeshi Yokoyama4, Tomohiro Nishizawa 1,
Tsukasa Kusakizako 1, Takafumi Kato1, Tatsuya Hagino1, Naoshi Dohmae5, Masato Inoue6,
Kengo Watanabe 6, Hidenori Ichijo 6, Masahide Kikkawa 7, Mikako Shirouzu 4, Thomas J. Jentsch 8,
Ryuichiro Ishitani1, Yasunobu Okada9,10✉ & Osamu Nureki 1✉
Members of the leucine-rich repeat-containing 8 (LRRC8) protein family, composed of the
five LRRC8A-E isoforms, are pore-forming components of the volume-regulated anion
channel (VRAC). LRRC8A and at least one of the other LRRC8 isoforms assemble into
heteromers to generate VRAC transport activities. Despite the availability of the LRRC8A
structures, the structural basis of how LRRC8 isoforms other than LRRC8A contribute to the
functional diversity of VRAC has remained elusive. Here, we present the structure of the
human LRRC8D isoform, which enables the permeation of organic substrates through VRAC.
The LRRC8D homo-hexamer structure displays a two-fold symmetric arrangement, and
together with a structure-based electrophysiological analysis, revealed two key features. The
pore constriction on the extracellular side is wider than that in the LRRC8A structures, which
may explain the increased permeability of organic substrates. Furthermore, an N-terminal
helix protrudes into the pore from the intracellular side and may be critical for gating.
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In vertebrates, cell volume is regulated by various membranetransporters and channels, which protect against intracellularand extracellular osmotic alterations1. The volume-regulated
anion channel (VRAC), also called the volume-sensitive out-
wardly rectifying anion channel or volume-sensitive organic
osmolyte-anion channel, is an anion channel activated upon cell
swelling. The VRAC-mediated transport of chloride ions and
small organic compounds, including osmolytes such as taurine or
glutamate, drives water efflux to counteract cell swelling2,3. The
leucine-rich repeat-containing 8 (LRRC8) protein family, com-
posed of the five isoforms LRRC8A to LRRC8E, was recently
identified as a pore-forming component of the VRAC4,5. Bio-
chemical and biophysical analyses demonstrated that hetero-
hexamers containing at least one LRRC8A isoform and at least
one of the other four LRRC8 isoforms (LRRC8B-LRRC8E) form
functional VRAC channels4,6–8. The isoform combinations
forming LRRC8 hetero-hexamers underlie the functional diver-
sity of the channel properties, including open probability7, gating
kinetics4,9, and substrate specificity8,10. However, LRRC8A
homo-hexamers can still form functional, although not physio-
logical, channels with much smaller swelling-induced currents,
when overexpressed in HEK293 cells with the disruption of all
five human LRRC8 genes11,12. Among the five LRRC8 isoforms,
the LRRC8D isoform is the largest one owing to a long first
extracellular loop between the transmembrane (TM) 1 and 2
helices13. When incorporated into LRRC8 hetero-hexamers, the
LRRC8D isoform facilitates the permeation of uncharged sub-
strates such as taurine and GABA, negatively charged glutamate,
and even positively charged lysine8,10. Moreover, LRRC8D-
containing hetero-hexamers facilitate the uptake of the anti-
biotic blasticidin S14 and the Pt-based anticancer drug cisplatin10,
resulting in cancer drug resistance in patients with down-
regulated LRRC8D isoforms10.
The recently determined single-particle cryo-electron
microscopy (cryo-EM) structures of the human and mouse
LRRC8A homo-hexamers in either detergent or lipid
nanodiscs, as well as the lower resolution structure of mouse
LRRC8A/C hetero-hexamers in detergent, provided the struc-
tural framework for hexamer formation, ion permeation, and
recognition of a VRAC-specific inhibitor in the LRRC8 protein
family11,15–17. The ion-selective pore of LRRC8 hexamers is
located along the central axis and is formed by the N-terminal
half of each of the six subunits, with a similar topology to the
pannexin and gap junction channels, including connexins and
innexins18–22. Recent electrophysiological analyses demon-
strated that the first several N-terminal residues preceding the
TM1 helix16,23 and the first extracellular loop (EL1) between
the TM1 and TM2 helices9,12 are involved in the diversity of
channel properties, including ion permeability and selectivity
as well as the kinetics of inactivation. In all previously deter-
mined LRRC8 structures, however, the structures of both the
N-terminal and EL1 regions remained unresolved due to their
flexibility11,15–17. In addition, the structural basis of how
LRRC8 isoforms other than LRRC8A contribute to the ion
permeation and diversity of VRAC functions has remained
elusive, due to the lack of high-resolution structures of other
LRRC8 isoforms. The LRRC8D isoform is particularly inter-
esting, because its incorporation into heteromers is requisite for
the permeation of many organic substrates, independent of
their electrical charge. In this study, we determined the struc-
ture of the human LRRC8D homo-hexamer, including the
N-terminal region, by cryo-EM single-particle analysis, and
conducted a structure-based electrophysiological analysis to
investigate the mechanism underlying the contribution of the
LRRC8D isoform to the LRRC8 protein function.
Results
Structure determination of human LRRC8D protein. When
expressed in Sf9 insect cells from Spodoptera frugiperda, which
lacks endogenous LRRC8 genes13, fluorescence-detection size-
exclusion chromatography24 of the C-terminally EGFP-tagged
human LRRC8D (HsLRRC8D; the “Hs” refers to Homo sapiens)
protein showed a sharp and monodisperse peak with a similar
elution volume to that of the human LRRC8A (HsLRRC8A)
protein, with structures determined by cryo-EM single-particle
analysis15,16, indicating that the HsLRRC8D protein is a pro-
mising candidate for structural analysis (Supplementary Fig. 1a).
A mass spectrometry analysis of the purified HsLRRC8D protein
sample from Sf9 insect cells confirmed that the sample contains
no LRRC8 isoforms other than HsLRRC8D and that the
HsLRRC8D protein exists as a homomer (Supplementary Fig. 1b,
c; Supplementary Data 1). To assess the functional properties of
HsLRRC8D, we performed whole-cell patch-clamp analyses using
HEK293 cells, in which all five human LRRC8 genes (LRRC8−/−
cells) were disrupted and swelling-induced currents were not
observed (Supplementary Fig. 1d, e)4. As shown in Supplemen-
tary Fig. 1d, e and consistent with previous reports4,11,12,
LRRC8−/− cells co-transfected with the HsLRRC8A wild type and
HsLRRC8D wild type plasmids (HsLRRC8A/D) showed swelling-
induced currents, and those transfected with the HsLRRC8A wild
type plasmid (HsLRRC8A) alone showed slight swelling-induced
currents. LRRC8−/− cells transfected with only the HsLRRC8D
wild type plasmid (HsLRRC8D) showed no swelling-induced
currents, confirming the notion that the functional VRAC
channels are heteromers including the LRRC8A isoform as a
crucial component4. Since the uncertain and most likely variable
stoichiometry of the heteromeric LRRC8A/D channels greatly
complicates the determination of their structures, we opted to
elucidate the structure of HsLRRC8D homomers for comparison
with the previously determined structures of LRRC8A homo-
hexamers. Even if these homomers are non-functional in cells
under physiological conditions, they may reveal the structural
differences between LRRC8 isoforms that underlie the functional
diversity of VRACs. Therefore, we attempted to elucidate the
structure of the HsLRRC8D homomer.
The purified HsLRRC8D protein was vitrified on grids, and
images were recorded by electron microscopy (Supplementary
Fig. 2b). The final 3D map was reconstructed to an overall 4.36 Å
resolution (local resolution of the transmembrane region is
~3.9 Å) with C2 symmetry imposed, and contained six subunits
of HsLRRC8D (hereafter referred to as α to ζ subunits)
(Supplementary Fig. 2a, c–f; Supplementary Table 1). Using the
previously determined structures of LRRC8A homo-hexamers in
detergent (PDB 5ZSU and 6G9O) as a guide, we assigned the
topologies of the HsLRRC8D regions, including the extracellular,
transmembrane (TM), intracellular, and leucine-rich repeat
(LRR) regions (Supplementary Fig. 2e). Data collection, refine-
ment, and validation statistics for the cryo-EM structure are
shown in Table 1.
Overall structure. Overall, HsLRRC8D adopts a homo-
hexameric architecture composed of four regions: extracellular,
TM, and intracellular regions in the N-terminal half of each
subunit, and a leucine-rich repeat (LRR) region contained in the
C-terminal half (Fig. 1). The overall HsLRRC8D structure is
largely consistent with the three previously determined LRRC8A
structures in detergent11,15,16 or nanodiscs17, with some excep-
tions (Fig. 1; Supplementary Figs. 3 and 4a–e). Among the pre-
viously reported LRRC8A structures, unless otherwise noted, we
mainly used our human LRRC8A structure (PDB ID: 5ZSU)15 for
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comparison with HsLRRC8D, since the structure determination
conditions are the most similar. The overall HsLRRC8D structure
displays a twofold symmetric “dimer of trimers” arrangement; in
other words, the structures of the α and δ subunits, those of the β
and ε subunits, and those of the γ and ζ subunits are identical
(Figs. 1 and 2). In contrast, the overall assembly of LRRC8A
homomers in detergent displayed a threefold symmetric “trimer
of dimers” arrangement, whereas LRRC8A homomers in nano-
discs displayed a sixfold symmetric arrangement in the TM
region and conformational heterogeneity in the LRR region, due
to its flexibility (Figs. 1 and 2; Supplementary Fig. 3)11,15–17. The
previous comparisons of LRRC8A structures in either detergent
or nanodiscs suggested that detergent micelles play an important
role in promoting the threefold symmetric arrangement of the
TM region, whereas nanodiscs with an included lipid bilayer
promote the sixfold symmetric arrangement17. Our HsLRRC8D
structure revealed that, in addition to the threefold and sixfold
symmetries, LRRC8 hexamers can form twofold symmetry.
However, further studies are required to confirm whether these
structural arrangements occur in the lipid-embedded heteromers
containing the LRRC8A isoform; i.e., under physiological
conditions.
Each subunit of HsLRRC8D has two extracellular loops (EL1
and EL2), four transmembrane helices (TM1-4), and two
intracellular loops (IL1 and IL2) in the N-terminal half, and an
LRR domain that contains the leucine-rich repeat N-terminal
helix (LRRNT), 15 leucine-rich repeats (LRR1–15), and the
following leucine-rich repeat C-terminal helix (LRRCT) in the C-
terminal half (Fig. 1b). Notably, we discovered an additional N-
terminal helix (NTH) (Fig. 1b; Supplementary Figs. 4a and 6),
which was not observed in the previously reported LRRC8A
structures (Supplementary Fig. 4b–e)11,15–17. It is formed by the
N-terminal residues preceding the TM1 helix and protrudes into
the channel pore, as in the previous structures of the
connexin18,19,25 and innexin20,22 channels (Supplementary
Fig. 5a, b), which show weak homology to LRRC8 proteins
(Fig. 1b; Supplementary Figs. 4a–e and 6)13.
Pore constriction. The channel pore of the HsLRRC8D structure
is located along the central axis perpendicular to the cell
Table 1 Cryo-EM data collection, refinement, and validation
statistics.
HsLRRC8D (EMD-30029)
(PDB 6M04)
Data collection and processing
Magnificationa x23,500
Voltage (kV) 200
Electron exposure (e–/Å2) 50
Defocus range (μm) 0.5–2.5
Pixel size (Å) 1.490
Symmetry imposed C2
Initial particle images (no.) 2,056,807
Final particle images (no.) 247,154
Map resolution (Å) 0.143
FSC threshold
Map resolution range (Å) 3.9–6.0
Refinement
Initial model used (PDB code) 5ZSU, 6G9O
Model resolution (Å) 0.5
FSC threshold
Model resolution range (Å) 4.36
Map sharpening B factor (Å2) −211.2
Model composition
Non-hydrogen atoms 34,666
Protein residues 4282
B factors (Å2)
Protein 106.9
R.m.s. deviations
Bond lengths (Å) 0.007
Bond angles (°) 1.288
Validation
MolProbity score 2.38
Clashscore 10.11
Poor rotamers (%) 2.06
Ramachandran plot
Favored (%) 87.11
Allowed (%) 12.85
Disallowed (%) 0.05
aCalibrated pixel size at the detector.
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Fig. 1 Overall structure and subunit interactions of the HsLRRC8D hexamer. a The overall structure of the HsLRRC8D hexamer, viewed parallel to the
membrane (left) and from the extracellular (right, upper) and intracellular (right, lower) sides. b A subunit of the HsLRRC8D structure, viewed parallel to
the membrane. According to the previously proposed HsLRRC8A hexamer structure (PDB ID: 5ZSU)15, each region is colored as follows: NTH dark gray,
TM1 purple, EL1 blue, TM2 light blue, IL1 cyan, TM3 green, EL2 light green, TM4 yellow, IL2 orange, LRRNT red, LRR1-15 pink, and LRRCT brown. The N- and
C-termini are indicated by ‘N’ and ‘C’, respectively. The molecular graphics were illustrated with CueMol (http://www.cuemol.org/).
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Fig. 2 Comparisons of the HsLRRC8D and HsLRRC8A structures. a, b Overall structures of the HsLRRC8D (a) and HsLRRA8A (PDB ID: 5ZSU)15
(b) hexamers, viewed parallel to the membrane (left) and from the intracellular side (right). c Superimposition of the HsLRRC8D (colored according to
Fig. 1b) and the HsLRRC8A (gray) structures, using the Cα atoms of the protomers. The structures are depicted in cylinder representations with molecular
surfaces.
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membrane. In agreement with the previously determined
LRRC8A structures, it is constricted at the N-terminal tip of a
helix (EL1H) on the extracellular side (Fig. 3a–c)11,15–17. The
sequence alignment predicted that the most constricted site is
formed by the Phe143 residue, as its aromatic ring restricts the
pore diameter to 11.5 Å (Fig. 3b–d; Supplementary Fig. 4a).
Notably, this value is close to the previously reported native
VRAC pore diameters of 11.4-14.2 Å, estimated by measuring
calixarene conductance in endothelial cells26, and 12.6 Å obtained
by differential polymer partitioning in epithelial cells27. In con-
trast, the pore diameters are 7.6–9.6 Å in the previously deter-
mined LRRC8A structures11,15–17, in which the corresponding
residue is replaced by Arg103, with its positively charged side
chain. Hence, the pore diameter at the most constricted external
site is narrower in LRRC8A than in LRRC8D homomers (Fig. 3b,
c; Supplementary Fig. 4a–e). Considering that LRRC8 proteins
physiologically form hetero-hexamers, this difference in the pore
diameters at the most constricted site between the LRRC8D and
LRRC8A homomer structures suggests that the inclusion of the
LRRC8D isoform into LRRC8A-containing heteromers may be
structurally involved in the increased permeability of VRACs to
organic substrates.
To investigate the functional importance of the residue at the
constricted site, we created the HsLRRC8D F143R mutant to
yield a heteromeric channel with only arginine at the constricted
site, and performed an electrophysiological analysis to assess the
permeability of various anions using LRRC8−/− cells co-
transfected with HsLRRC8A wild type and HsLRRC8D wild type
or HsLRRC8D F143R mutant plasmids (HsLRRC8A/D and
HsLRRC8A/D (F143R), respectively). As compared to
HsLRRC8A/D, the HsLRRC8A/D (F143R) channel showed
decreased permeability to negatively charged glutamate and
gluconate (Fig. 3e, f). Furthermore, while the HsLRRC8A/D
channel showed higher permeability for glutamate than for
gluconate, the HsLRRC8A/D (F143R) channel showed similar
permeability to glutamate and gluconate (Fig. 3e, f). These results
suggested that the mutation from the non-charged phenylalanine
to the positively charged arginine changes the electrostatic effects
and tightens the pore size at the constricted site on the
extracellular side, thus exhibiting a greater effect on tightening
the pore size than on changing the electrostatic effect, thereby
leading to a reduction, rather than an increase, in the permeability
to glutamate and gluconate (Fig. 3f). However, further structural
analyses are required to understand the precise effect of the
mutation from phenylalanine to arginine, since the structure of
the HsLRRC8D F143R mutant has not been determined. Notably,
previous reports indicated that the positive charge and the
bulkiness of Arg103 may be involved in the anion selectivity
filter11 and the pore blockage by extracellular ATP16, respectively.
Our results suggest that the replacement of Arg103 by Phe143 in
LRRC8D may increase the permeability of VRAC to organic
compounds, predominantly by an increase in the pore diameter.
N-terminal helix. Importantly, unlike the previously determined
LRRC8A structures11,15–17 (Supplementary Fig. 4b–e), we
observed an additional N-terminal helix (NTH) located in the TM
region innermost to the channel pore (Figs. 3b, d and 4a; Sup-
plementary Figs. 4a and 6), entering the channel pore from the
cytoplasmic side, similar to the connexin18,19,25 and innexin20,22
structures (Supplementary Fig. 5) and consistent with a previous
mutagenesis study of LRRC8/VRAC channels23. The NTH is
formed by the Ala5 to Asn11 residues at the N-terminal region
preceding the TM1 helix and closely interacts with the TM1 helix
(Figs. 3b, d and 4a; Supplementary Fig. 4a). In the HsLRRC8D
structure, the Leu4, Val7, and Leu10 residues face the channel
pore, whereas the Ala5, Ser9, and Asp12 residues face the TM1
helix (Figs. 3b, d and 4a; Supplementary Figs. 4a and 6). To
investigate whether the NTH observed in the HsLRRC8D struc-
ture is formed in functional LRRC8 hetero-hexamers, we created a
series of cysteine mutants in the N-terminal region of the
HsLRRC8D protein, and performed an electrophysiological ana-
lysis to monitor the accessibility of the thiol-reactive reagent 2-
sulfonatoethyl methane-thiosulfonate (MTSES), using LRRC8−/−
cells co-transfected with HsLRRC8A wild type and one of the
HsLRRC8D mutants. All mutants showed swelling-induced cur-
rents (Fig. 4b; Supplementary Data 2). For the mutations at Val7
and Leu10, MTSES reduced the swelling-induced currents,
whereas MTSES enhanced them for the mutation of Leu4 (Fig. 4c,
d; Supplementary Data 2), demonstrating that these residues are
accessible from the aqueous phase. These electrophysiological
results are consistent with the HsLRRC8D structure, in which
these three residues face the channel pore (Fig. 4a). On the basis of
the present data, including the HsLRRC8D structure and the
electrophysiological experiments in HsLRRC8A/D channels, as
well as the previous electrophysiological results observed in
LRRC8A/C, LRRC8A/D, and LRRC8A/E channels23, we conclude
that the N-terminal region in the HsLRRC8D protein serves as a
pore-forming helix in LRRC8D homo-hexamers and functional
LRRC8A/D hetero-hexamers, similar to the cases of connexin and
innexin.
Discussion
In this study, we present the 4.36 Å resolution cryo-EM structure
of the human LRRC8D homo-hexamer, the largest isoform in the
LRRC8 protein family, which is important to increase the per-
meability to organic substrates in VRAC (Fig. 1). The overall
assembly of HsLRRC8D adopts the homo-hexameric archi-
tecture, consistent with the previously determined LRRC8A
homo-hexameric structures11,15–17. However, while the
HsLRRC8D structure displayed a twofold symmetric “dimer of
trimers” arrangement, the LRRC8A structures displayed threefold
symmetric “trimer of dimers” or sixfold symmetric arrangements,
suggesting the conformational flexibility of the LRRC8 protein
family (Fig. 2). Since LRRC8 proteins form hetero-hexamers
under physiological conditions, further studies are needed to
investigate the subunit–subunit interactions of the functional
LRRC8 hetero-hexamers in cells.
As predicted by the sequence alignment13 and the previously
determined LRRC8A structures11,15–17, the channel pore of the
HsLRRC8D structure is located along the central axis and con-
stricted at the N-terminal tip of EL1H on the extracellular side by
the Phe143 residue (Fig. 3a–d), which corresponds to the Arg103
residue in the LRRC8A structures (Fig. 3d)11,15–17. Notably, the
diameter of the most constricted site on the extracellular side is
wider in the HsLRRC8D structure than in the LRRC8A struc-
tures. Our electrophysiological analysis using the LRRC8D F143R
mutant suggested that the uncharged phenylalanine residue plays
an important role in the substrate permeability, by adjusting the
pore size in the LRRC8 protein family (Fig. 3e, f). The wider
external opening of LRRC8D than that of the LRRC8A homo-
mers might underlie the increased permeability of LRRC8D-
containing VRACs for organic substrates including negatively
charged glutamate and gluconate (Fig. 3f), as well as uncharged
substrates such as taurine, GABA, and cisplatin8,10, although it
remains undetermined whether the structure actually represents
an open conformation of this channel. In the TM region
innermost to the channel pore, an additional NTH preceding
the TM1 helix is observed (Figs. 3b–d and 4a; Supplementary
Fig. 4a), similar to the connexin and innexin structures in
which the NTH is thought to be crucial for channel gating
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Fig. 3 Role of pore constriction in anion selectivity. a Cross-sections of the surface representation for the N-terminal half of the HsLRRC8D subunits,
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diagonal subunits viewed parallel to the membrane are shown. The side chains of the pore-lining amino acid residues from NTH, TM1, and EL1H are
depicted in stick representations. The distances between the residues involved in the pore constrictions are shown. c The pore radii for the HsLRRC8D and
HsLRRC8A (PDB ID: 5ZSU)15 structures. The pore size was calculated with the program HOLE37. d Sequence alignment of the human LRRC8 isoforms
around the pore constriction formed by the extracellular and TM regions. The amino acid sequences were aligned using Clustal Omega38, and are shown
using ESPript339. The NTH, TM1, and EL1H regions of HsLRRC8D are labeled above the alignments. For the sequence alignment, the following human
LRRC8 isoforms were used: HsLRRC8A, NCBI Reference sequence number: NP_062540.2; HsLRRC8B, NP_056165.1; HsLRRC8C, NP_115646.2;
HsLRRC8D, NP_060573.2; and HsLRRC8E, AAH70089.1. The amino acid residue involved in the pore constriction on the extracellular side is highlighted
with an orange dot. e Representative current traces of swelling-induced currents in response to voltage ramps of −100 to +100mV, in one LRRC8−/− cell
co-transfected with HsLRRC8A wild type and HsLRRC8D wild type (left), and another LRRC8−/− cell co-transfected with HsLRRC8A wild type and
HsLRRC8D F143R mutant (right). f Relative anion selectivity (Px/PCl) calculated from the shifts of the reversal potential induced by the replacement of
chloride ions with other anions. Data are means ± SEM (n= 5–6). *P < 0.05 compared to the data from LRRC8−/− cells co-transfected with HsLRRC8A wild
type and HsLRRC8D wild type. P values were calculated by the Student’s t test.
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(Supplementary Fig. 5)18–21,25. Further structure-based electro-
physiological analyses using a cysteine modifier supported that
the NTH observed in the HsLRRC8D structure also exists in the
LRRC8A/D hetero-hexamer, with channel entry from the cyto-
plasmic side. Whether the other LRRC8 proteins also form the
NTH observed here remains to be shown. However, a secondary
structure prediction of the N-terminal regions of the five LRRC8
isoforms suggested that all LRRC8 isoforms may form the NTH
(Supplementary Fig. 4f), and the notion that the LRRC8 N-
termini line the VRAC pore is strongly supported by the recent
mutagenesis study by Zhou et al.23. Using a series of double
cysteine mutants of the N-terminal residues in the LRRC8A/C,
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LRRC8A/D, and LRRC8A/E channels, Zhou et al.23 demonstrated
that these residues are involved in channel properties, such as ion
permeability and kinetics of inactivation. In particular, Zhou
et al.23 found that the conserved Glu6 is important for anion
selectivity and thus predicted that the N-terminal regions form
part of the channel pore. These results are consistent with the
HsLRRC8D structure in which Glu6 also faces the channel pore,
as shown in Fig. 4a and Supplementary Fig. 6. Furthermore, Zhou
et al.23 reported that the anion selectivity changes induced by the
double cysteine mutations at Glu6 are greater in the LRRC8A/C
channels than those in the LRRC8A/D and LRRC8A/E channels.
These results suggest that the sequence diversity at the N-terminal
region is important for substrate permeability, which might affect
the reactivity of MTSES to the mutations at Glu6. Together with
the electrophysiological data, the present cryo-EM structure,
which is the first to resolve the N-terminus of LRRC8D to our
knowledge, now clearly demonstrates that the NTH of LRRC8D
participates in forming the channel pore.
In summary, the pore constriction on the extracellular side in
LRRC8D homo-hexamers is wider than that in LRRC8A homo-
hexamers, and the NTH participates in the formation of the
innermost pore by protruding into the intracellular entrance.
These results present the structural framework for understanding
the mechanism underlying the contribution of the LRRC8D
isoform to the functions and properties of VRAC.
Methods
Protein expression, purification, and sample preparation for cryo-EM. Protein
expression, purification, and sample preparation were performed as described
previously15, except that Sf9 insect cells from Spodoptera frugiperda (ATCC, CRL-
1711) were used as the protein expression host. The human LRRC8D wild-type
protein (NCBI Reference sequence number: NP_060573.2) was cloned from
human brain cDNA (ZYAGEN) into the pFastBac1 vector (Thermo Fisher Sci-
entific), with a C-terminal GFP-His8 tag and a tobacco etch virus (TEV) cleavage
site, and was expressed in Sf9 insect cells. Cells were collected by centrifugation
(5000 × g, 10 min, 4 °C) and disrupted by sonication in buffer (50 mM Tris, pH 8.0,
150 mM NaCl) supplemented with 5.2 µg mL−1 aprotinin, 2 µg mL−1 leupeptin,
and 1.4 µg mL−1 pepstatin A (all from Calbiochem). Cell debris was removed by
centrifugation (10,000 × g, 10 min, 4 °C). The membrane fraction was collected by
ultracentrifugation (138,000 × g, 1 h, 4 °C). The membrane fraction was solubilized
for 1 h at 4 °C in buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 5 mM dithiothreitol,
1% digitonin (Calbiochem)). Insoluble materials were removed by ultra-
centrifugation (138,000 × g, 1 h, 4 °C). The detergent-soluble fraction was incu-
bated with CNBr-Activated Sepharose 4 Fast Flow beads (GE Healthcare) coupled
with an anti-GFP nanobody28 and incubated for 1 h at 4 °C. The beads were
washed with size-exclusion chromatography buffer (50 mM Tris, pH 8.0, 150 mM
NaCl, 5 mM dithiothreitol, and 0.1% digitonin), and further incubated overnight
with TEV protease to remove the GFP-His8 tag. After TEV protease digestion, the
flow-through was collected, concentrated, and purified by size-exclusion chroma-
tography on a Superose 6 Increase 10/300 GL column (GE Healthcare), equili-
brated with size-exclusion chromatography buffer. The peak fractions of the
protein were collected and concentrated to 3 mgmL−1, using a centrifugal filter
unit (Merck Millipore, 100 kDa molecular weight cutoff). A 3-µL portion of the
concentrated HsLRRC8D protein was applied to a glow-discharged Quantifoil
R1.2/1.3 Cu/Rh 300 mesh grid (Quantifoil), blotted using a Vitrobot Mark IV (FEI)
under 4 °C and 100% humidity conditions, and then frozen in liquid ethane.
EM image acquisition and data processing. The grid images were obtained with
a Tecnai Arctica transmission electron microscope (FEI) operated at 200 kV, and
recorded by a K2 Summit direct electron detector (Gatan) operated in the super-
resolution mode with a binned pixel size of 1.490 Å. The dataset was acquired with
the SerialEM software29. Each image was dose-fractionated to 40 frames at a dose
rate of 6–8 e− pixel−1 per second, to accumulate a total dose of ~50 e− Å−2. In
total, 3397 super-resolution movies were collected. The movie frames were aligned
in 5 × 5 patches, dose weighted and binned by two in MotionCor230, and down-
sampled by two. Defocus parameters were estimated by CTFFIND 4.131. First,
template-based auto-picking was performed with the 2D class averages of a few
hundred manually picked particles as templates32. A total of 2,056,807 particles
were extracted in 3.25 Å pix−1. These particles were divided into two batches and
subjected to three rounds of 2D classification in RELION 2.132,33. The initial model
was generated in RELION. Subsequently, 1,062,374 good particles were further
classified in 3D without symmetry. Finally, 247,154 particles in classes 6 and 7 with
six intact subunits were re-extracted in the original pixel size of 1.49 Å pix−1 and
refined in C2 symmetry. The overall gold-standard resolution was 4.36 Å, with the
local resolution in the core TM region extending to 3.9 Å and that in the peripheral
region extending to 6.0 Å (Table 1 and Supplementary Fig. 2d).
Model building. De novo atomic modeling was conducted in COOT34, using the
HsLRRC8A (PDB ID: 5ZSU) and MmLRRC8A (PDB ID: 6G9O) structures as
guides. The initial model was rebuilt using Rosetta35 against the density maps,
manually readjusted using COOT, and then refined using PHENIX36 with sec-
ondary structure restraints.
Mass spectrometry. The purified HsLRRC8D protein (2.1 mg mL−1, 50 μL) was
reduced, carboxymethylated, desalted, and digested with trypsin (TPCK-treated,
Worthington Biochemical Corporation). An aliquot of the digest was subjected to
nano-liquid chromatography-tandem mass spectrometry, using a Q Exactive mass
spectrometer (Thermo Fisher Scientific). The peptide mixtures (~1 μg) were
separated on a nano ESI spray column (75 μm (inside diameter) × 100 mm
(length), NTCC analytical column C18, 3 μm, Nikkyo Technos), with a gradient of
0–64% buffer B (acetonitrile with 0.1% (v/v) formic acid) in buffer A (MilliQ water
with 0.1% (v/v) formic acid) at a flow rate of 300 nL min−1 over 30 min (EASY-
nLC 1000; Thermo Fisher Scientific). The mass spectrometer was operated in the
positive-ion mode for mass spectrometry and tandem mass spectrometry, and
the tandem mass spectrometry spectra were acquired using the data-dependent
TOP 10 method. The tandem mass spectrometry data were used to search the
NCBI-nr protein database (20160711, Taxonomy: H. sapiens 326,427 sequences)
with the Mascot (version 2.6.0, Matrix Science) search engine, using the following
parameters: enzyme = trypsin; maximum missed cleavages= 3; variable mod-
ifications=Acetyl (Protein N-term), Gln- > pyro-Glu (N-term Q), Oxidation (M);
product mass tolerance= ±15 ppm; product mass tolerance= ±30 milli mass unit;
instrument type= ESI-TRAP, and then quantified with the Proteome Discoverer
2.2 (Thermo Fisher Scientific) software package. All mass spectrometry data are
presented in Supplementary Data 1 and have been deposited to the Proteo-
meXchange Consortium via the PRIDE partner repository with the dataset iden-
tifier PXD018780 and 10.6019/PXD018780.
Cell culture for electrophysiology. Human embryonic kidney HEK293 cells with
the disruption of all five human LRRC8 genes (LRRC8−/− cells)4 were grown as a
monolayer in Dulbecco’s Modified Eagle’s Medium (DMEM), supplemented with
10% fetal bovine serum, 40 units mL−1 penicillin G, and 100 µg mL−1 strepto-
mycin under a 95% air, 5% CO2 atmosphere at 37 °C. For electrophysiological
experiments, cells were detached from the plastic substrate and cultured in sus-
pension with agitation for 15–300 min.
Patch-clamp experiments. LRRC8−/− cells were grown to ~80% confluency
(24–48 h after plating) in a 35-mm diameter dish. For patch-clamp experiments,
cells were transfected using Lipofectamine 2000 (Thermo Fisher Scientific) trans-
fection reagents with recombinant plasmids: pIRES2-AcGFP1-HsLRRC8A wild
type, pIRES2-DsRed-HsLRRC8D wild type, pIRES2-DsRed-HsLRRC8D-F2C
(F2C), pIRES2-DsRed-HsLRRC8D-T3C (T3C), pIRES2-DsRed-HsLRRC8D-L4C
(L4C), pIRES2-DsRed-HsLRRC8D-A5C (A5C), pIRES2-DsRed-HsLRRC8D-E6C
(E6C), pIRES2-DsRed-HsLRRC8D-V7C (V7C), pIRES2-DsRed-HsLRRC8D-A8C
(A8C), pIRES2-DsRed-HsLRRC8D-S9C (S9C), and pIRES2-DsRed-HsLRRC8D-
L10C (L10C). When co-transfecting plasmids for HsLRRC8A wild type and
HsLRRC8D wild type, or for HsLRRC8A wild type and HsLRRC8D mutant, we
selected a cell where both green and red fluorescent proteins were observed to
confirm their simultaneous expression in the cell.
Whole-cell recordings were performed at room temperature (22–26 °C). Patch
pipettes were pulled from borosilicate glass capillaries with a micropipette puller
(P-97; Sutter Instruments, Novato, CA, USA). The electrode had a resistance of
~2–4 megaohms for whole-cell recordings when filled with pipette solution.
Currents were recorded using an Axopatch 200B amplifier (Axon Instruments/
Molecular Devices, Union City, CA, USA). Current signals were filtered at 5 kHz
using a four-pole Bessel filter and digitized at 20 kHz. The pClamp software
(version 10.5.1.0; Axon Instruments/Molecular Devices) was used for command
pulse control, data acquisition, and analysis. Data were analyzed using the Origin
(OriginLab Corp., Northampton, MA, USA) software. For whole-cell recordings,
the series resistance was compensated (to 70–80%) to minimize voltage errors.
Ramp pulses were applied every 15 s from −100 mV to +100 mV at a speed of
0.8 mVms−1, from a holding potential (Vh) of 0 mV. The intracellular (pipette)
solution contained (in mmol L−1): 110 NMDG-Cl, 2 MgSO4, 10 HEPES, 1 EGTA,
and 2 Na2ATP (pH adjusted to 7.3 with NMDG). The bath solution contained
(in mmol L−1): 110 NMDG-Cl, 5 MgSO4, and 10 HEPES (pH adjusted to 7.4
with NMDG). For experiments on the effects of MTSES, the osmolality was
adjusted with D-mannitol to 360 (hypertonic) and 330 (isotonic) mosmol kgH2O−1
in the pipette and bath solutions, respectively. For anion selectivity experiments,
the osmolality was adjusted with D-mannitol to 300 mosmol kgH2O−1 in the
pipette solution and 275 (hypotonic) and 330 (isotonic) mosmol kgH2O−1 in
the bath solution. The time courses of current activation and inhibition were
monitored by repetitively applying alternating step pulses to ±40 mV (500 ms
duration, every 15 s) from a holding potential of 0 mV. For anion selectivity
experiments, a 3-mol L−1 KCl-agar salt bridge was used to minimize changes in the
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liquid junction potentials when changing the bath solution from that containing
110 mmol L−1 NMDG-Cl to that containing 110 mmol L−1 NMDG-Br, NMDG-I,
NMDG-glutamate, or NMDG-gluconate. The anion permeability ratio (Px/PCl) was
calculated from a shift in the reversal potential by the Goldman–Hodgkin–Katz
Equation. The substituted-cysteine accessibility method (SCAM) analysis was
performed with MTSES in LRRC8−/− cells expressing cysteine-substituted mutants
of HsLRRC8D. MTSES (1 mmol L−1) was added to the bath solution, after the
whole-cell HsLRRC8A/D currents reached plateau values in the cells swollen by the
hypertonic pipette solution.
Statistics and reproducibility. The sample sizes and statistical analyses used in
patch-clamp recordings are presented in the legend of each figure.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The raw image of HsLRRC8D after motion correction has been deposited in the Electron
Microscopy Public Image Archive (EMPIAR), under the accession number EMPIAR-
10383. The cryo-EM density map of HsLRRC8D has been deposited in the Electron
Microscopy Data Bank (EMDB), under the accession number EMD-30029. The
molecular coordinates of HsLRRC8D have been deposited in the RCSB Protein Data
Bank (PDB), under the accession number 6M04. All mass spectrometry data are available
in Supplementary Data 1 and the ProteomeXchange Consortium with identifier
PXD018780.
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